Joseph Lucchese - 20 Aug 2023 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Reporting relationship: EVP & CFO
Issuer ticker: N/A
Reported as of: 20 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Aug 2023, 19:43:35 UTC
Prior SEC filing: 18 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ Joseph Lucchese

Key filing fact

Joseph Lucchese filed Form 4 for Timber Pharmaceuticals, Inc. on 22 Aug 2023.

Key facts

This page summarizes Joseph Lucchese's Form 4 filing for Timber Pharmaceuticals, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Aug 2023, 19:43.

Change

Previous filing in this sequence was filed on 18 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMBR transaction

Common Stock, par value $0.001

Award

Transaction value: $0
Shares: +35,193
Change %
Price: $0.000000
Shares after: 35,193
Date: 20 Aug 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On August 20, 2023, the Reporting Person was granted 35,193 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.001. 25% of the RSUs vest on August 20, 2024, and the remaining RSUs vest in 36 equal monthly installments beginning on September 20, 2024, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date; provided, however, that the RSUs will vest in full in the event that a "Change in Control" (as defined in the Issuer's 2020 Omnibus Incentive Plan) occurs while the Reporting Person remains in continuous service with the Issuer.